# Anavex Life Sciences Corp.: Form 8-K, filed Sep 2, 2026

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: 8-K
- Filed: 2026-09-02
- Accepted by EDGAR: Sep 2, 2026, 17:06 ET
- Period: 2026-09-02
- Accession: 0001731122-26-001179
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/e7909_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/e7909_8-k.htm

Filed Sep 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001731122-26-001179. Last ingested by Listed: Nov 6, 2026, 20:17 ET. No prices; not investment advice.